|
1）石井榮一．乳児白血病の発症機序とその治療．日本臨牀．2007; 65 Suppl 1: 686-94
|
|
|
|
2）富澤大輔，磯山恵一，石井榮一．乳児期発症の急性リンパ性白血病に対するMLL遺伝子再構成の有無による層別化治療．臨床血液．2008; 49: 171-81
|
|
|
|
|
3）Zweidler-McKay PA, Hilden JM. The ABCs of infant leukemia. Curr Probl Pediatr Adolesc Health Care. 2008; 38: 78-94
|
|
|
|
|
|
4）石井榮一．乳児白血病研究の進歩．臨床血液．2009; 50: 1500-5
|
|
|
|
|
|
5）Eguchi M, Eguchi-Ishimae M, Greaves M. Molecular pathogenesis of MLL-associated leukemias. Int J Hematol. 2005; 82: 9-20
|
|
|
|
|
6）Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1: 133-43
|
|
|
|
|
|
7）Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10: 125-34
|
|
|
|
|
|
8）Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003; 102: 2951-9
|
|
|
|
|
|
9）Ross ME, Mahfouz R, Onciu M, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood. 2004; 104: 3679-87
|
|
|
|
|
|
10）Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet. 2002; 30: 41-7
|
|
|
|
|
|
11）Tsutsumi S, Taketani T, Nishimura K, et al. Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res. 2003; 63: 4882-7
|
|
|
|
|
|
12）Stam RW, Schneider P, Hagelstein JA, et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood. 2010; 115: 2835-44
|
|
|
|
|
|
13）De Braekeleer E, Douet-Guilbert N, Le Bris M-J, et al. Gene expression profiling of adult t(4; 11)(q21; q23)-associated acute lymphoblastic leukemia reveals a different signature from pediatric cases. AntiCancer Res. 2012; 32: 3893-9
|
|
|
|
|
|
14）Andersson A, Olofsson T, Lindgren D, et al. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc Natl Acad Sci U S A. 2005; 102: 19069-74
|
|
|
|
|
|
15）Nagayama J, Tomizawa D, Koh K, et al. Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group. Blood. 2006; 107: 4663-5
|
|
|
|
|
|
16）Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007; 370: 240-50
|
|
|
|
|
|
17）Andersson A, Eden P, Olofsson T, et al. Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies. BMC Medical Genomics. 2010; 3: 6
|
|
|
|
|
|
18）Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005; 435: 834-8
|
|
|
|
|
|
19）Mi S, Lu J, Sun M, et al. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A. 2007; 104: 19971-6
|
|
|
|
|
|
20）Schotte D, Chau JC, Sylvester G, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia. 2009; 23: 313-22
|
|
|
|
|
|
21）Schotte D, De Menezes RX, Akbari Moqadam F, et al. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011; 96: 703-11
|
|
|
|
|
|
22）Haferlach T, Kohlmann A, Schnittger S, et al. Global approach to the diagnosis of leukemia using gene expression profiling. Blood. 2005; 106: 1189-98
|
|
|
|
|
|
23）Holleman A, Cheok MH, den Boer ML, et al. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med. 2004; 351: 533-42
|
|
|
|
|
|
24）Lugthart S, Cheok MH, den Boer ML, et al. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell. 2005; 7: 375-86
|
|
|
|
|
|
25）Trentin L, Giordan M, Dingermann T, et al. Two independent gene signatures in pediatric t(4;11) acute lymphoblastic leukemia patients. Eur J Haematol. 2009; 83: 406-19
|
|
|
|
|
|
26）Starkova J, Zamostna B, Mejstrikova E, et al. HOX gene expression in phenotypic and genotypic subgroups and low HOXA gene expression as an adverse prognostic factor in pediatric ALL. Pediatr Blood Cancer. 2010; 55: 1072-82
|
|
|
|
|
|
27）Kang H, Wilson CS, Harvey RC, et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Childrenʼs Oncology Group study. Blood. 2012; 119: 1872-81
|
|
|
|
|